43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 14
18:23 UTC
|
JCAP
Jernigan Capital
|
◎ Target | Danielle Brill ★★★☆☆ #2034 | Buy | $26.00→ $30.00+15.4% |
|
Aug 14
18:23 UTC
|
JCAP
Jernigan Capital
|
◎ Target | Robert Dodd ★★★☆☆ #1456 | Outperform | $21.00→ $24.00+14.3% |
|
Aug 14
18:23 UTC
|
GLOB
Globant
|
◎ Target | Arvind Ramnani ★★☆☆☆ #2287 | Hold | $44.00→ $38.00-13.6% |
|
Aug 14
18:23 UTC
|
FLYW
Flywire
|
◎ Target | Matthew Coad ★★★★☆ #377 | Hold | $17.00→ $19.00+11.8% |
|
Aug 14
18:23 UTC
|
FLNC
Fluence Energy
|
◎ Target | Vikram Bagri ★☆☆☆☆ #2982 | Buy | $24.00→ $20.00-16.7% |
|
Aug 14
18:23 UTC
|
EMR
Emerson Electric
|
◎ Target | Varun Govindaraj not yet tracked | Outperform | $169.00→ $186.00+10.1% |
|
Aug 14
18:23 UTC
|
DT
Dynatrace
|
◎ Target | Miller Jump ★★★★☆ #339 | Buy | $55.00→ $60.00+9.1% |
|
Aug 14
18:23 UTC
|
CRWV
CoreWeave
|
◎ Target | Tyler Radke ★★★★★ #316 | Buy | $142.00→ $159.00+12.0% |
|
Aug 14
18:23 UTC
|
BWXT
BWX Technologies
|
◎ Target | Alexandra Mandery not yet tracked | Hold | $212.00→ $202.00-4.7% |
|
Aug 14
18:23 UTC
|
BTGO
BTGO
|
◎ Target | Peter Christiansen ★★★☆☆ #2124 | Buy | $17.00→ $10.00-41.2% |
|
Aug 14
18:23 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Christopher Glynn ★★★☆☆ #1763 | Outperform | $350.00→ $390.00+11.4% |
|
Aug 14
18:23 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Michael Lewis ★★★★☆ #800 | Buy | $57.00→ $61.00+7.0% |
|
Aug 14
17:23 UTC
|
WHF
WhiteHorse Finance
|
◎ Target | Sean-Paul Adams ★★★☆☆ #1415 | Neutral | $7.50→ $8.00+6.7% |
|
Aug 14
17:23 UTC
|
TGT
Target
|
◎ Target | Peter Keith ★★★★☆ #579 | Neutral | $127.00→ $146.00+15.0% |
|
Aug 14
17:23 UTC
|
SMR
NuScale Power
|
◎ Target | Ryan Pfingst ★☆☆☆☆ #3070 | Buy | $19.00→ $15.00-21.1% |
|
Aug 14
17:23 UTC
|
OCS
Oculis
|
◎ Target | Tessa Romero ★★☆☆☆ #2524 | Overweight | $23.00→ $20.00-13.0% |
|
Aug 14
17:23 UTC
|
HON
Honeywell International
|
◎ Target | Chigusa Katoku not yet tracked | Overweight | $262.00→ $255.00-2.7% |
|
Aug 14
17:23 UTC
|
GLOB
Globant
|
◎ Target | Tien-Tsin Huang not yet tracked | Neutral | $47.00→ $44.00-6.4% |
|
Aug 14
17:23 UTC
|
CREX
Creative Realities
|
◎ Target | Jon Hickman ★☆☆☆☆ #3031 | Buy | $7.50→ $8.00+6.7% |
|
Aug 14
17:23 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Brian Essex ★★★☆☆ #1338 | Overweight | $20.00→ $16.00-20.0% |
|
Aug 14
17:23 UTC
|
BLSH
Bullish
|
◎ Target | Kenneth Worthington not yet tracked | Neutral | $26.00→ $25.00-3.8% |
|
Aug 14
17:23 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Yaron Werber ★★★☆☆ #2161 | Buy | $325.00→ $341.00+4.9% |
|
Aug 14
16:22 UTC
|
YSWY
Yesway
|
◎ Target | Thomas Palmer ★★★☆☆ #1674 | Neutral | $25.00→ $27.00+8.0% |
|
Aug 14
16:22 UTC
|
VTR
Ventas
|
◎ Target | Michael Carroll ★★★★☆ #692 | Outperform | $98.00→ $99.00+1.0% |
|
Aug 14
16:22 UTC
|
UPB
Upstream Bio
|
◎ Target | Tessa Romero ★★☆☆☆ #2524 | Neutral | $8.00→ $9.00+12.5% |
|
Aug 14
16:22 UTC
|
SNDK
Sandisk
|
◎ Target | Srini Pajjuri ★★☆☆☆ #2416 | Sec→ r Perform | $1,300.00→ $1,600.00+23.1% |
|
Aug 14
16:22 UTC
|
SJM
J. M. Smucker
|
◎ Target | Thomas Palmer ★★★☆☆ #1674 | Overweight | $125.00→ $139.00+11.2% |
|
Aug 14
16:22 UTC
|
RLAY
Relay Therapeutics
|
◎ Target | Priyanka Grover ★★☆☆☆ #2696 | Overweight | $28.00→ $31.00+10.7% |
|
Aug 14
16:22 UTC
|
OMDA
Omada Health
|
◎ Target | Lisa Gill ★★★★☆ #707 | Overweight | $26.00→ $30.00+15.4% |
|
Aug 14
16:22 UTC
|
MSGS
Madison Square Garden
|
◎ Target | David Karnovsky ★★★★★ #153 | Overweight | $450.00→ $485.00+7.8% |
|
Aug 14
16:22 UTC
|
MGTX
MeiraGTx
|
◎ Target | Lisa Walter ★★☆☆☆ #2744 | Outperform | $26.00→ $27.00+3.8% |
|
Aug 14
16:22 UTC
|
LUNR
Intuitive Machines
|
◎ Target | Mike Crawford ★★☆☆☆ #2651 | Buy | $45.00→ $43.00-4.4% |
|
Aug 14
16:22 UTC
|
LFST
LifeStance Health Group
|
◎ Target | Lisa Gill ★★★★☆ #707 | Neutral | $9.00→ $13.00+44.4% |
|
Aug 14
16:22 UTC
|
HTFL
Heartflow
|
◎ Target | Robbie Marcus ★★★★★ #224 | Overweight | $35.00→ $45.00+28.6% |
|
Aug 14
16:22 UTC
|
HRL
Hormel Foods
|
◎ Target | Thomas Palmer ★★★☆☆ #1674 | Neutral | $25.00→ $26.00+4.0% |
|
Aug 14
16:22 UTC
|
GLOB
Globant
|
◎ Target | Bryan C. Bergin not yet tracked | Buy | $47.00→ $45.00-4.3% |
|
Aug 14
16:22 UTC
|
ESS
Essex Property Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1091 | Underweight | $275.00→ $295.00+7.3% |
|
Aug 14
16:22 UTC
|
DELL
Dell Technologies
|
◎ Target | Aaron Rakers ★★★☆☆ #1666 | Overweight | $505.00→ $545.00+7.9% |
|
Aug 14
16:22 UTC
|
CRMD
CorMedix
|
◎ Target | Leonid Timashev ★★★☆☆ #1319 | Outperform | $13.00→ $14.00+7.7% |
|
Aug 14
16:22 UTC
|
BN
Brookfield
|
◎ Target | Mario Saric ★★☆☆☆ #2548 | Sec→ r Outperform | $53.00→ $54.00+1.9% |
|
Aug 14
16:22 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Priyanka Grover ★★☆☆☆ #2696 | Overweight | $27.00→ $25.00-7.4% |
|
Aug 14
16:22 UTC
|
B
Barrick Mining
|
◎ Target | Bennett Moore ★★★☆☆ #1857 | Overweight | $50.00→ $52.00+4.0% |
|
Aug 14
16:22 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Luca Issi ★★★☆☆ #1921 | Outperform | $280.00→ $290.00+3.6% |
|
Aug 14
15:22 UTC
|
WYFI
WhiteFiber
|
◎ Target | Raimo Lenschow ★★★★☆ #709 | Equal Weight | $29.00→ $32.00+10.3% |
|
Aug 14
15:22 UTC
|
WSM
Williams-Sonoma
|
◎ Target | Steven Shemesh ★★★★☆ #917 | Outperform | $192.00→ $260.00+35.4% |
|
Aug 14
15:22 UTC
|
WBI
WBI
|
◎ Target | Praneeth Satish ★★★☆☆ #2245 | Equal Weight | $26.00→ $28.00+7.7% |
|
Aug 14
15:22 UTC
|
TPR
Tapestry
|
◎ Target | Adrienne Yih ★★★☆☆ #1568 | Overweight | $182.00→ $185.00+1.6% |
|
Aug 14
15:22 UTC
|
SNOW
Snowflake
|
◎ Target | Matthew Hedberg ★★★★☆ #497 | Outperform | $313.00→ $372.00+18.8% |
|
Aug 14
15:22 UTC
|
SAIL
SailPoint
|
◎ Target | Matthew Hedberg ★★★★☆ #497 | Outperform | $19.00→ $22.00+15.8% |
|
Aug 14
15:22 UTC
|
RUN
Sunrun
|
◎ Target | Praneeth Satish ★★★☆☆ #2245 | Overweight | $22.00→ $17.00-22.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.